Portal de Periódicos da CAPES

Empiric Auto-Titrating CPAP in People with Suspected Obstructive Sleep Apnea

2010; American Academy of Sleep Medicine; Volume: 06; Issue: 02 Linguagem: Inglês

10.5664/jcsm.27762

1550-9397

Fitzgerald Drummond, Peter Doelken, Qanta A. Ahmed, Gregory E. Gilbert, Charlie Strange, Laura Herpel, Michael D. Frye,

Congenital Heart Disease Studies

Free AccessCPAPEmpiric Auto-Titrating CPAP in People with Suspected Obstructive Sleep Apnea Fitzgerald Drummond, M.D., Peter Doelken, M.D., Qanta A. Ahmed, M.D., Gregory E. Gilbert, MSPH, Charlie Strange, M.D., Laura Herpel, M.D., Michael D. Frye, M.D. Fitzgerald Drummond, M.D. Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Ralph H. Johnson VA Medical Center and Medical University of South Carolina, Charleston, SC , Peter Doelken, M.D. Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Ralph H. Johnson VA Medical Center and Medical University of South Carolina, Charleston, SC , Qanta A. Ahmed, M.D. Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Ralph H. Johnson VA Medical Center and Medical University of South Carolina, Charleston, SC , Gregory E. Gilbert, MSPH Department of Biometry, Bioinformatics, and Epidemiology, Medical University of South Carolina, Charleston, SC , Charlie Strange, M.D. Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Ralph H. Johnson VA Medical Center and Medical University of South Carolina, Charleston, SC , Laura Herpel, M.D. Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Ralph H. Johnson VA Medical Center and Medical University of South Carolina, Charleston, SC , Michael D. Frye, M.D. Address correspondence to: Michael Frye, M.D., Chief, Pulmonary Section, Medical Specialties Service, Ralph H. Johnson VA Medical Center, Charleston, SC, 29425(843) 792-3161(843) 792-0732 E-mail Address: [email protected] Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Ralph H. Johnson VA Medical Center and Medical University of South Carolina, Charleston, SC Published Online:April 15, 2010https://doi.org/10.5664/jcsm.27762Cited by:16SectionsAbstractPDF ShareShare onFacebookTwitterLinkedInRedditEmail ToolsAdd to favoritesDownload CitationsTrack Citations AboutABSTRACTObjective:Efficient diagnosis and treatment of obstructive sleep apnea (OSA) can be difficult because of time delays imposed by clinic visits and serial overnight polysomnography. In some cases, it may be desirable to initiate treatment for suspected OSA prior to polysomnography. Our objective was to compare the improvement of daytime sleepiness and sleep-related quality of life of patients with high clinical likelihood of having OSA who were randomly assigned to receive empiric auto-titrating continuous positive airway pressure (CPAP) while awaiting polysomnogram versus current usual care.Methods:Serial patients referred for overnight polysomnography who had high clinical likelihood of having OSA were randomly assigned to usual care or immediate initiation of auto-titrating CPAP. Epworth Sleepiness Scale (ESS) scores and the Functional Outcomes of Sleep Questionnaire (FOSQ) scores were obtained at baseline, 1 month after randomization, and again after initiation of fixed CPAP in control subjects and after the sleep study in auto-CPAP patients.Results:One hundred nine patients were randomized. Baseline demographics, daytime sleepiness, and sleep-related quality of life scores were similar between groups. One-month ESS and FOSQ scores were improved in the group empirically treated with auto-titrating CPAP. ESS scores improved in the first month by a mean of −3.2 (confidence interval −1.6 to −4.8, p < 0.001) and FOSQ scores improved by a mean of 1.5, (confidence interval 0.5 to 2.7, p = 0.02), whereas scores in the usual-care group did not change (p = NS). Following therapy directed by overnight polysomnography in the control group, there were no differences in ESS or FOSQ between the groups. No adverse events were observed.Conclusion:Empiric auto-CPAP resulted in symptomatic improvement of daytime sleepiness and sleep-related quality of life in a cohort of patients awaiting polysomnography who had a high pretest probability of having OSA. Additional studies are needed to evaluate the applicability of empiric treatment to other populations.Citation:Drummond F; Doelken P; Ahmed QA; Gilbert GE; Strange C; Herpel L; Frye MD. Empiric auto-titrating CPAP in people with suspected obstructive sleep apnea. J Clin Sleep Med 2010;6(2):140-145.INTRODUCTIONUntreated obstructive sleep apnea syndrome (OSAS) is associated with significant morbidity and mortality,1–8 mandating prompt recognition and timely treatment. Current standards of care include clinical assessment followed by 1 or more in-laboratory attended polysomnography studies.9BRIEF SUMMARYCurrent Knowledge/Study Rationale: We observed that the waiting times for overnight sleep studies can delay treatment of patients with obstructive sleep apnea and we wished to find a way to expedite treatment. This study aimed to evaluate the safety and efficacy of empiric auto-titrating CPAP in patients awaiting a sleep study who clinically had a high likelihood of having sleep apnea and no comorbidities.Study Impact: This study suggests that empiric treatment with auto-titrating CPAP can reduce the time to effective treatment of OSA while awaiting overnight polysomnography. This study shows that empiric treatment of suspected OSA with auto-titrating CPAP is safe and effective.Currently, the United States has the highest ratio of sleep laboratory beds per capita in the world, performing more than 1.1 million polysomnography annually.10 However, with obesity on an exponential rise, now estimated at 31% of all Americans,11,12 significant pressure on sleep-bed capacities exist.A variety of alternatives to in-laboratory intervention have been proposed. Clinical prediction rules have helped target patients with OSA.13,14 Home monitoring is actively implemented in Europe. Although gaining momentum, evidenced-based US guidelines suggest that typical home monitoring is insufficiently robust for clinical use.15 Recent reimbursement approval may change this dynamic.Some clinical trials16,17 have suggested that empiric treatment with automatically adjusting continuous positive airway pressure (auto-CPAP) is a reasonable choice for patients with a high clinical likelihood of having OSA. Other investigators have suggested the use of a CPAP-challenge as a potential diagnostic tool.18 Few have published objective efficacy outcomes using these approaches.To evaluate the efficacy of empiric auto-CPAP in patients awaiting polysomnography, we conducted a trial comparing empiric auto-CPAP therapy to usual care in consecutive patients referred for polysomnography. The primary outcomes included the Epworth Sleepiness Scale (ESS) and Functional Outcomes of Sleep Questionnaire (FOSQ).METHODSPatientsConsecutive patients referred for polysomnography at the Ralph H. Johnson VA Medical Center in Charleston, SC, from April 2004 to February 2006 were evaluated. Patients were excluded for age greater than 80 years, a history of congestive heart failure, myocardial infarction in the prior 6 months, chronic obstructive pulmonary disease with a forced expiratory volume in 1 second of less than 60% predicted, stroke, alternate sleep diagnosis, or a prior diagnosis of OSA. Those responding to the telephone inquiry were screened with the Berlin questionnaire13 and offered enrollment if 2 or more categories of the Berlin questionnaire were positive.Study DesignThis prospective, randomized, controlled pilot trial was approved by the Medical University of South Carolina Institutional Review Board for Human Research and the Ralph H. Johnson Veterans Administration Research Committee. Once enrolled, subjects were randomly assigned by sealed envelope to either the auto-CPAP group or the usual-care group. Primary endpoints were the ESS score19 and the FOSQ score20 in the 2 groups at various time points. A secondary endpoint was the time to begin treatment of OSAS.InstrumentsThe ESSThe ESS18 is a validated questionnaire that scores the subjective likelihood of dozing in 8 distinct situations ranging from 0 (no likelihood) to 3 (high likelihood). The maximum possible score is 24, and normal is considered by most investigators as 8 or less. Although an imperfect tool,21 the ESS is widely used to track changes in daytime hypersomnolence during therapy for OSAS.22,23The FOSQThe FOSQ is a 30-item self-report tool designed to assess the impact of excessive daytime somnolence on activities of daily living.19 Higher scores suggest less negative impact. FOSQ scores increase with OSAS therapy.24 A normal score has been estimated to be at least 18.20,25ProtocolEligible patients agreeing to participate were seen in an initial clinic visit during which informed consent was obtained and a physical examination performed. Patients completed the ESS and FOSQ prior to randomization. Patients were randomly assigned by sealed envelope to either the auto-CPAP group or the usual-care group. A flow diagram showing the study protocol and the number of patients at each point is presented as Figure 1.Figure 1 Flow diagram for the research protocol.Download FigureAuto-CPAP GroupSubjects randomly assigned to the auto-CPAP group were issued a cost-free auto-CPAP unit on the day of randomization (Respironics Remstar-Auto, Murraysville, PA).The pressure range was set from +5 to +20 cm H2O. Mask fitting and instructions on use were provided by a CPAP coordinator.At 1 month from randomization and initiation of auto-CPAP, subjects returned to the clinic and completed a second ESS and FOSQ and a questionnaire about their symptomatic satisfaction with auto-CPAP and compliance. Subjects then remained on auto-CPAP and awaited an attended in-laboratory polysomnogram and CPAP titration. Approximately 1 month after polysomnography, patients returned to the clinic and completed the third and final ESS and FOSQ. At that time, they were placed on fixed CPAP based on the results of their in-laboratory studies, and their involvement in the study protocol ended.Usual-Care GroupSubjects randomly assigned to the usual-care group completed the second ESS and FOSQ by mail approximately 1 month after randomization and continued to wait for in-laboratory polysomnography. Next, an attended in-laboratory polysomnogram was performed, and fixed-pressure CPAP was titrated via a split-night study or subsequent full-night CPAP titration. Fixed-pressure CPAP was then prescribed if indicated. Approximately 1 month after starting CPAP, patients were seen in the clinic and completed the third and final ESS and FOSQ. Their involvement in the study then ended.Polysomnography and CPAP TitrationAll patients underwent attended polysomnography and CPAP titration as they would have had they not been enrolled in the study. American Academy of Sleep Medicine scoring procedures were used. Hypopneas were scored with a 50% reduction in flow associated with an arousal or desaturation of 3%. Due to the high pretest probability for OSA and limited bed capacity, most sleep studies were split-night studies.Data AnalysisThe 2 primary endpoints were the ESS and FOSQ scores in the 2 groups. An intention-to-treat analytic strategy included all patients in each group.Primary data were analyzed using a 2-tailed student t test or 2-tailed Fisher exact test for categorical data and reported as mean ± SD. Missing data was imputed from baseline data using last observation carried forward. Paired t tests were used to compare ESS and FOSQ scores with their corresponding previous time points using p values adjusted by Bonferonni correction for multiple tests. All statistical analyses were performed using SAS version 9.1.3 (SAS Institute, Inc., Cary, NC) and JMP version 5 (SAS Institute, Inc.).RESULTSBaseline Patient CharacteristicsOne thousand twenty patients were referred for polysomnography between April 2004 and February 2006. OSAS had been previously diagnosed in 447 (44%) and they were therefore excluded. Another 234 (23%) patients were excluded based on other screening criteria. The remaining 339 (33%) patients were potential research subjects. Of these, 109 responded to an initial telephone inquiry, were eligible, and enrolled. Subjects were randomly assigned to auto-CPAP (N = 54) or usual care (N = 55). Table 1 shows the enrollees' demographic features, which did not differ significantly between the 2 groups.Table 1 Baseline CharacteristicsAuto-CPAP (n = 54)Usual Care (n = 55)p value Age, y55.4 ± 10.355.0 ± 13.70.44Men (%)9691 0.67aRace (n)0.22a African American2114 Caucasian3341BMI, kg/m235.3 ± 6.834.9 ± 5.40.30Mallampati Score3.07 ± 1.03.25 ± 0.90.15 Neck size, in18.0 ± 1.517.8 ± 1.50.27 Baseline Questionnaires, scores ESS14.8 ± 4.914.1 ± 5.00.23 FOSQ14.0 ± 3.614.3 ± 3.30.30 Data are shown as mean ± SD, except men, which is percentage, and race, which is number. CPAP refers to continuous positive airway pressure; BMI, body mass index; ESS, Epworth Sleepiness Scale; FOSQ, Functional Outcomes of Sleep Questionnaire.aTwo-tailed Fisher exact test.PolysomnographyEighty-six subjects (79%) completed the entire protocol, including polysomnography: 42 (78%) in the auto-CPAP group and 44 (80%) in the usual-care group. This 80% completion rate is comparable to the completion rate for sleep studies in our VA patient population. A total of 23 patients did not complete the protocol: 12 (22%) in the auto-CPAP group, and 11 (20%) in the usual-care group. Reasons given for not completing the protocol included patients seeking care elsewhere, moving outside of the service area, changing their minds about having a sleep study, and withdrawal from the research protocol.Of the patients undergoing polysomnography, 82 (95%) met diagnostic criteria for OSAS with an apnea-hypopnea index (AHI) of more than 5 per hour and symptoms of excess daytime sleepiness. Four patients (5%) did not meet diagnostic criteria for OSAS: 3 in the usual-care group and 1 in the auto-CPAP group. The AHI for these 4 patients ranged from 3.2 to 4.3. The results of the attended polysomnograms for the 2 groups are collated in Table 2.Table 2 Results of Attended PolysomnographyAuto-CPAP (n = 42)Usual Care (n = 44)p value AHI43.8 ± 30.937.0 ± 29.10.15 AHI > 5/h97.695.10.62aMin SaO2, %87.2 ± 6.781.4 ± 10.80.002 CPAP pressureb10.3 ± 2.49.3 ± 2.50.07 Data are shown as mean ± SD, except apnea-hypopnea index (AHI) > 5, which is percentage. SaO2 refers to the minimum oxyhemoglobin concentration.aTwo-tailed Fisher exact test.bThe recommended continuous positive airway pressure (CPAP) pressure by titration included 32 in the Auto-CPAP group and 34 in the usual-care group.Efficacy of Empiric Auto-titrating CPAPAt the baseline evaluation, the groups did not differ in ESS or FOSQ scores (see Table 1). At the second time point (approximately 1 month after enrollment), ESS scores improved in the auto-CPAP group from 14.8 ± 4.9 to 11.6 ± 5.4 (mean improvement 3.2, 95% confidence interval [CI] −1.6 to 4.8) but was unchanged in the usual-care group (14.1 ± 5.0 to 14.1 ± 4.7) (p < 0.001 in comparison of treatment effects).FOSQ scores also improved in the auto-titrating CPAP group, from 14.0 ± 3.6 to 15.5 ± 3.0 (Mean improvement 1.5, 95% CI 0.5 to 2.7); whereas, in the usual-care group, the FOSQ score was unchanged (14.2 ± 3.3 to 14.2 ± 3.5; p = 0.02 in comparison of treatment effects).At the final time point after the attended polysomnogram and CPAP titration, both the auto-CPAP and usual-care groups showed significant improvement over their respective initial ESS and FOSQ scores. The final ESS was not different between the auto-CPAP and usual-care groups (11.1 ± 5.6 vs 12.7 ± 5.0, respectively, p = 0.13). The final FOSQ was similar between auto-CPAP and usual-care groups (15.7 ± 3.1 vs 14.6 ± 3.8, respectively, p = 0.10)In an effort to compare efficacy of empiric auto-CPAP more directly to usual care, the ESS and FOSQ data for the auto-CPAP group after 1 month of therapy (data point 2) were compared to the ESS and FOSQ data for the usual-care group after those patients had been on CPAP for approximately 1 month (data point 3). No difference was found between the ESS (11.6 ± 5.4 and 12.7 ± 5.0; p = 0.25) or the FOSQ (15.5 ± 3.0 and 14.6 ± 3.8; p = 0.17) for the auto-CPAP group and usual-care group, respectively. These data are presented in Figure 2.Figure 2 Results of the Epworth Sleepiness Scale (ESS) and Functional Outcomes of Sleep Questionnaire (FOSQ) for the auto-continuous positive airway pressure (CPAP) and usual-care groups (mean ± SD) at the 3 study time points.Download FigureSafety and ComplicationsThere were no subject deaths or cerebrovascular accidents during the study period. Five patients (12%) in the auto-CPAP group and 4 (9%) in the usual-care group were admitted to the hospital for chest pain. All but 1 had negative cardiac workups. One patient in the usual-care group underwent coronary stent placement for non–ST-elevation MI. No motor vehicle crashes or other catastrophic adverse events were reported.Time to TreatmentPatients randomly assigned to auto-CPAP began treatment for OSA on the day of randomization and waited an average of 184 ± 143 days for polysomnography. Patients randomly assigned to usual care waited an average of 144 ± 97 days for polysomnography and were started on CPAP within 30 days of polysomnography.DISCUSSIONWe found empiric auto-titrating CPAP to be effective in reducing sleepiness and improving the quality of life of patients with a high likelihood of having OSA while awaiting a polysomnogram. The degree of improvement was comparable to usual care with attended in-laboratory diagnostic polysomnography and CPAP titration. Furthermore, auto-CPAP appears to be safe when used empirically in select patients and resulted in a significant reduction in time to treatment.Despite optimal therapy in both treatment groups, many patients did not achieve normal measures of wakefulness and sleep-related quality of life. This pattern has been observed in other studies as well.26 Weaver et al.27 assessed patients with OSA before and 3 months after treatment with CPAP using the ESS, FOSQ, and Multiple Sleep Latency Test. In that study, 52% of patients using CPAP for 6 hours per night remained sleepy by objective Multiple Sleep Latency Test measurement, and 22% remained sleepy by subjective assessment. Patients may report sleepiness due to other sleep-related problems, such as inadequate duration or frequent arousals. Patients may also perceive symptoms of unrelated comorbid illnesses, such as fatigue, lethargy, or weakness, as sleepiness. Permanent changes in the sleep and wake mechanisms of some patients with OSA are also implicated.28 In our VA population of predominantly older men with comorbid illnesses, the ability of the ESS and FOSQ to completely normalize with treatment of OSA may be limited despite effective therapy. Inadequate compliance may have also contributed to residual sleepiness in our study population.We relied on the Berlin score to help determine OSA likelihood. The success of the Berlin instrument to identify OSA in this study was 95%, higher than many previous reports. This likely is due to the high prevalence of OSA in patients referred to our laboratory. It is unknown whether current screening tools are sufficiently robust to predict auto-CPAP responsiveness in populations with a lower prevalence of OSAS. Moreover, the success of empiric auto-CPAP in this study is at least in part related to the high pretest probability for OSA and the exclusion of patients at risk for having central apnea.Treatment with CPAP prior to polysomnography has been associated with a reduction in the AHI felt to be related to a decrease in airway inflammation and edema.30 We did not observe any significant difference in the results of polysomnography in the 2 groups despite treatment with auto-CPAP for an extended period prior to polysomnography. This could be related to differences in auto-CPAP and fixed CPAP, differences in the severity of disease in the population studied, or that the population size was not adequate to show such differences.Most studies of patients with confirmed OSA have shown comparable efficacy between auto-CPAP and fixed-CPAP.31–40 We evaluated efficacy of empiric auto-titrating CPAP in terms of participant sleepiness and quality of life, as measured by ESS and FOSQ. Although there is evidence to suggest variability in the ESS of individual patients over multiple administrations,41 such variability should have occurred in both groups equally.A small group of our patients completely normalized their ESS and FOSQ on auto-titrating CPAP within 1 month of therapy. Although not evaluated in this study, individuals treated empirically with auto-CPAP who become completely asymptomatic might be able to entirely forgo an attended in-laboratory polysomnogram and CPAP-titration study. The safety and efficacy of long-term empiric auto-CPAP therapy or empiric fixed-CPAP therapy needs to be assessed.There were no adverse events related to the use of empiric auto-titrating CPAP during this study. However, the study was not powered to directly compare survival or event-free survival. In the future, a longitudinal study of greater duration and magnitude could be conducted to directly compare long-term outcomes in empiric auto-titrating CPAP therapy and usual care. Improvement in mortality is proven for usual-care CPAP treatment of OSA but has not yet been studied in patients treated empirically with auto-CPAP.LimitationsAlthough data from this study suggest a role for empiric auto-titrating CPAP, this study is limited in some ways. The study was conducted in a population with a high pretest probability for having OSA and in the setting of long wait times for diagnosis and treatment of OSA. These conditions may not exist at many sleep centers. The high pretest probability for having OSA was, however, ideal for evaluating efficacy of empiric treatment. Likewise, the long wait time resulted in empiric treatment lasting several months, whereas, at many sleep centers, it may have lasted only a few weeks. Although these factors make for an excellent population in which to study empiric treatment, it also limits the ability to generalize our findings. Similar studies in other patient populations and for longer periods are needed.Furthermore, of the 1020 patients referred for a polysomnogram, only 109 were enrolled in the study. Many patients already had a diagnosis of OSA (n = 447). However, 234 were excluded due to comorbid illness. Although empiric treatment appears to be safe in the group studied, patients with comorbid disease that would put them at risk for having central apnea were excluded. This limitation of the study population was felt to be necessary for patient-safety reasons.Objective measures of improvement and compliance were not utilized and would have considerably strengthened our findings. Objective compliance monitoring was not available at the study center at the time the study was conducted. Objective measures of improvement (e.g., maintenance of wakefulness testing or driving simulation) likewise were not available at the study center at the time of the trial.Although patient follow-up was not perfect, the difference in ESS scores at 1 month is striking, despite statistical challenges imposed by an intention-to-treat study design. Furthermore, the completion rate for the study of about 80% mirrors the completion rate for patients referred for a sleep study.In summary, both the degree of improvement and the number of patients who improved were similar between empiric auto-titrating CPAP and usual-care groups. Symptomatic benefit in ESS and FOSQ occurred in more than 80% of both groups, comparable with typical success rates of fixed-pressure CPAP.42 Further studies are needed to better define the role of empiric auto-CPAP in the treatment of patients with sleep disordered breathing.DISCLOSURE STATEMENTThis was not an industry supported study. The authors have indicated no financial conflicts of interest.REFERENCES1 Arias MAAlonso-Fernandez AGarcia-Rio FObstructive sleep apnea as an independent risk factor for stroke and mortalityStroke2006371150, 16556874CrossrefGoogle Scholar2 Marti SSampol GMunoz X, et al.Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatmentEur Respir J20022015111518, 12503712CrossrefGoogle Scholar3 Wang HParker JDNewton GE, et al.Influence of obstructive sleep apnea on mortality in patients with heart failureJ Am Coll Cardiol20074916251631, 17433953CrossrefGoogle Scholar4 Stoohs RAFacchini FGuilleminault CInsulin resistance and sleep-disordered breathing in healthy humansAm J Respir Crit Care Med1996154170174, 8680675CrossrefGoogle Scholar5 Stoohs RAGingold JCohrs S, et al.Sleep-disordered breathing and systemic hypertension in the older maleJ Am Geriatr Soc19964412951300, 8909343CrossrefGoogle Scholar6 Marshall NSWong KKLiu PY, et al.Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health StudySleep20083110791085, 18714779Google Scholar7 Young TFinn LPeppard PE, et al.Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohortSleep20083110711078, 18714778Google Scholar8 Yaggi HKConcato JKernan WN, et al.Obstructive sleep apnea as a risk factor for stroke and deathN Engl J Med200535320342041, 16282178CrossrefGoogle Scholar9 Kushida CALittner MRMorgenthaler T, et al.Practice parameters for the indications for polysomnography and related procedures: an update for 2005Sleep200528499521, 16171294CrossrefGoogle Scholar10 Tachibana NAyas NTWhite DPA quantitative assessment of sleep laboratory activity in the United StatesJ Clin Sleep Med200512326, 17561611LinkGoogle Scholar11 Hensrud DDKlein SExtreme obesity: a new medical crisis in the United StatesMayo Clin Proc200681S510, 17036573CrossrefGoogle Scholar12 Pender JRPories WJEpidemiology of obesity in the United StatesGastroenterol Clin North Am20053417, 15823434CrossrefGoogle Scholar13 Netzer NCStoohs RANetzer CM, et al.Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndromeAnn Intern Med1999131485491, 10507956CrossrefGoogle Scholar14 Rowley JAAboussouan LSBadr MSThe use of clinical prediction formulas in the evaluation of obstructive sleep apneaSleep200023929938, 11083602CrossrefGoogle Scholar15 Executive summary on the systematic review and practice parameters for portable monitoring in the investigation of suspected sleep apnea in adultsAm J Respir Crit Care Med200416911601163, 15132960CrossrefGoogle Scholar16 Mulgrew ATFox NAyas NT, et al.Diagnosis and initial management of obstructive sleep apnea without polysomnography: a randomized validation studyAnn Intern Med2007146157166, 17283346CrossrefGoogle Scholar17 Nolan GMRyan SO'Connor TM, et al.Comparison of three auto-adjusting positive pressure devices in patients with sleep apnoeaEur Respir J200628159164, 16571610CrossrefGoogle Scholar18 Senn OBrack TRussi EW, et al.A continuous positive airway pressure trial as a novel approach to the diagnosis of the obstructive sleep apnea syndromeChest20061296775, 16424414CrossrefGoogle Scholar19 Johns MWA new method for measuring daytime sleepiness: the Epworth sleepiness scaleSleep199114540545, 1798888CrossrefGoogle Scholar20 Weaver TELaizner AMEvans LK, et al.An instrument to measure functional status outcomes for disorders of excessive sleepinessSleep199720835843, 9415942Google Scholar21 Miletin MSHanly PJMeasurement properties of the Epworth sleepiness scaleSleep Med20034195199, 14592321CrossrefGoogle Scholar22 Engleman HMMcDonald JPGraham D, et al.Randomized crossover trial of two treatments for sleep apnea/hypopnea syndrome: continuous positive airway pressure and mandibular repositioning splintAm J Respir Crit Care Med2002166855859, 12231497CrossrefGoogle Scholar23 Ballester EBadia JRHernandez L, et al.Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndromeAm J Respir Crit Care Med1999159495501, 9927363CrossrefGoogle Scholar24 Montserrat JMFerrer MHernandez L, et al.Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placeboAm J Respir Crit Care Med2001164608613, 11520724CrossrefGoogle Scholar25 Gooneratne NSWeaver TECater JR, et al.Functional outcomes of excessive daytime sleepiness in older adultsJ Am Geriatr Soc200351642649, 12752839CrossrefGoogle Scholar26 Faccenda JFMackay TWBoon NA, et al.Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndromeAm J Respir Crit Care Med2001163344348, 11179104CrossrefGoogle Scholar27 Weaver TEMaislin GDinges DF, et al.Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioningSleep200730711719, 17580592CrossrefGoogle Scholar28 Dinges DFWeaver TEEffects of modafinil on sustained attention performance and quality of life in OSA patients with residual sleepiness while being treated with nCPAPSleep Med20034393402, 14592280CrossrefGoogle Scholar29 Newman ABEnright PLManolio TA, et al.Sleep disturbance, psychosocial correlates, and cardiovascular disease in 5201 older adults: the Cardiovascular Health StudyJ Am Geriatr Soc19974517, 8994480CrossrefGoogle Scholar30 Corda LRedolfi SMontemurro LT, et al.Short- and long-term effects of CPAP on upper airway anatomy and collapsibility in OSAHSleep Breath200913187193, 18815823CrossrefGoogle Scholar31 Ayas NTPatel SRMalhotra A, et al.Auto-titrating versus standard continuous positive airway pressure for the treatment of obstructive sleep apnea: results of a meta-analysisSleep200427249253, 15124718CrossrefGoogle Scholar32 d'Ortho MPGrillier-Lanoir VLevy P, et al.Constant vs. automatic continuous positive airway pressure therapy: home evaluationChest200011810101017, 11035671CrossrefGoogle Scholar33 Hudgel DWFung CA long-term randomized, cross-over comparison of auto-titrating and standard nasal continuous airway pressureSleep200023645648, 10947032CrossrefGoogle Scholar34 Littner MHirshkowitz MDavila D, et al.Practice parameters for the use of auto-titrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome. An American Academy of Sleep Medicine reportSleep200225143147, 11902424CrossrefGoogle Scholar35 Lloberes PBallester EMontserrat JM, et al.Comparison of manual and automatic CPAP titration in patients with sleep apnea/hypopnea syndromeAm J Respir Crit Care Med199615417551758, 8970366CrossrefGoogle Scholar36 Massie CAMcArdle NHart RW, et al.Comparison between automatic and fixed positive airway pressure therapy in the homeAm J Respir Crit Care Med20031672023, 12406840CrossrefGoogle Scholar37 Meurice JCMarc ISeries FEfficacy of auto-CPAP in the treatment of obstructive sleep apnea/hypopnea syndromeAm J Respir Crit Care Med1996153794798, 8564134CrossrefGoogle Scholar38 Noseda AKempenaers CKerkhofs M, et al.Constant vs auto-continuous positive airway pressure in patients with sleep apnea hypopnea syndrome and a high variability in pressure requirementChest20041263137, 15249439CrossrefGoogle Scholar39 Senn OBrack TMatthews F, et al.Randomized short-term trial of two autoCPAP devices versus fixed continuous positive airway pressure for the treatment of sleep apneaAm J Respir Crit Care Med200316815061511, 14525804CrossrefGoogle Scholar40 Fietze IGlos MMoebus I, et al.Automatic pressure titration with APAP is as effective as manual titration with CPAP in patients with obstructive sleep apneaRespiration200774279286, 17337881CrossrefGoogle Scholar41 Nguyen ATBaltzan MASmall D, et al.Clinical reproducibility of the Epworth Sleepiness ScaleJ Clin Sleep Med20062170174, 17557491LinkGoogle Scholar42 McArdle NDevereux GHeidarnejad H, et al.Long-term use of CPAP therapy for sleep apnea/hypopnea syndromeAm J Respir Crit Care Med199915911081114, 10194153CrossrefGoogle Scholar Previous article Next article FiguresReferencesRelatedDetailsCited by Geer J, Karagoz E and Yaggi H Sleep apnea and stroke Encyclopedia of Sleep and Circadian Rhythms, 10.1016/B978-0-12-822963-7.00325-X, (271-277), . Palatal Coupling Maneuvers Do Not Predict Hypoglossal Nerve Stimulator Treatment EfficacyRenslo B, Hobelmann K, Sagalow E, Ananth A, Boon M and Huntley C The Laryngoscope, 10.1002/lary.30397 Endorsement of: "Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline" by World Sleep SocietyJacobowitz O, Afifi L, Penzel T, Poyares D, Marklund M and Kushida C Sleep Medicine, 10.1016/j.sleep.2021.10.007, , Online publication date: 1-Oct-2021. Effect of interventions to reduce wait times for diagnosis and treatment of sleep-disordered breathing in adults: A systematic reviewPerry S, Ronksley P, Kelly J and Pendharkar S Canadian Journal of Respiratory, Critical Care, and Sleep Medicine, 10.1080/24745332.2021.1874251, (1-18) Alternative Care Pathways for Obstructive Sleep Apnea and the Impact on Positive Airway Pressure AdherenceBillings M and Pendharkar S Sleep Medicine Clinics, 10.1016/j.jsmc.2020.10.005, , Online publication date: 1-Dec-2020. Telehealth, Telemedicine, and Obstructive Sleep ApneaSchutte-Rodin S Sleep Medicine Clinics, 10.1016/j.jsmc.2020.05.003, , Online publication date: 1-Jul-2020. Educating Stroke/TIA Patients about Obstructive Sleep Apnea after Stroke: A Randomized Feasibility StudyDharmakulaseelan L, Kirolos N, Kamra M, Armesto-Heys A, Bouthillier C, Runions S, Linkewich E, Murray B and Boulos M Journal of Stroke and Cerebrovascular Diseases, 10.1016/j.jstrokecerebrovasdis.2019.104317, Vol. 28, No. 11, (104317), Online publication date: 1-Nov-2019. Predicting Success of Oral Appliance Therapy in Treating Obstructive Sleep Apnea Using Drug-Induced Sleep EndoscopyHuntley C, Cooper J, Stiles M, Grewal R and Boon M Journal of Clinical Sleep Medicine, Vol. 14, No. 08, (1333-1337), Online publication date: 15-Aug-2018. Palen B and Benditt J Nocturnal Noninvasive Ventilation in Neuromuscular Ventilatory Disorders Nocturnal Non-Invasive Ventilation, 10.1007/978-1-4899-7624-6_5, (113-133), . Psychometric Performance and Responsiveness of the Functional Outcomes of Sleep Questionnaire and Sleep Apnea Quality of Life Index in a Randomized Trial: The HomePAP StudyBillings M, Rosen C, Auckley D, Benca R, Foldvary-Schaefer N, Iber C, Zee P, Redline S and Kapur V Sleep, 10.5665/sleep.4262, Vol. 37, No. 12, (2017-2024), Online publication date: 1-Dec-2014. Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea–hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressureSharples L, Glover M, Clutterbuck-James A, Bennett M, Jordan J, Chadwick R, Pittman M, East C, Cameron M, Davies M, Oscroft N, Smith I, Morrell M, Fox-Rushby J and Quinnell T Health Technology Assessment, 10.3310/hta18670, Vol. 18, No. 67, (1-296) New and Unconventional Treatments for Obstructive Sleep ApneaDe Dios J and Brass S Neurotherapeutics, 10.1007/s13311-012-0146-5, Vol. 9, No. 4, (702-709), Online publication date: 1-Oct-2012. Functional outcomes of sleep in Thai patients with obstructive sleep-disordered breathingBanhiran W, Assanasen P, Metheetrairut C, Nopmaneejumruslers C, Chotinaiwattarakul W and Kerdnoppakhun J Sleep and Breathing, 10.1007/s11325-011-0556-3, Vol. 16, No. 3, (663-675), Online publication date: 1-Sep-2012. Air Leak is Associated with Poor Adherence to Autopap TherapyValentin A, Subramanian S, Quan S, Berry R and Parthasarathy S Sleep, 10.5665/SLEEP.1054, Vol. 34, No. 6, (801-806), Online publication date: 1-Jun-2011., Online publication date: 1-Jun-2011. Perioperative management of adult and pediatric sleep apnoeaGothi D Indian Journal of Sleep Medicine, 10.5005/ijsm-6-2-35, Vol. 6, No. 2, (35-43), . APAP and Alternative Titration MethodsAhmed O and Parthasarathy S Sleep Medicine Clinics, 10.1016/j.jsmc.2010.05.010, Vol. 5, No. 3, (361-368), Online publication date: 1-Sep-2010. Volume 06 • Issue 02 • April 15, 2010ISSN (print): 1550-9389ISSN (online): 1550-9397Frequency: Monthly Metrics History Submitted for publicationJanuary 1, 2009Submitted in final revised formJuly 1, 2009Accepted for publicationSeptember 1, 2009Published onlineApril 15, 2010 Information© 2010 American Academy of Sleep MedicineKeywordsAuto-CPAPEpworth sleepiness ScaleOSASOSAFunctional Outcomes of Sleep Questionnaireobstructive sleep apneaACKNOWLEDGMENTSThis material is the result of work supported with resources and the use of facilities at the Ralph H. Johnson VA Medical Center, Charleston, SC.PDF download